Q2 2016 Holdings
Filed 2016-08-15 | 48 holdings | $56.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biomarin Pharmaceutical Inc(BMRN) | Common | 09061G101 | $33.7M | 432,972 | 59.7% |
| Acadia Pharmaceuticals Inc(ACAD) | Common | 004225108 | $10.7M | 329,500 | 19.0% |
| Cytokinetics Inc.(CYTK) | Common | 23282W605 | $4.8M | 503,900 | 8.5% |
| Akebia Therapeutics Inc(AKBA) | Common | 00972D105 | $4.7M | 621,873 | 8.2% |
| Cellectis(CLLS) | Sponsored ADS | 15117K103 | $1.1M | 42,671 | 2.0% |
| Corvus Pharmaceuticals Inc(CRVS) | Common | 221015100 | $1.1M | 74,800 | 1.9% |
| Tesaro Inc | Common | 881569107 | $43.2K | 514,000 | 0.1% |
| Lion Biotechnologies Inc | Common | 53619R102 | $35.1K | 4,338,557 | 0.1% |
| Celator Pharmaceuticals Inc. | Common | 15089R102 | $33.9K | 1,124,666 | 0.1% |
| Bristol Myers Squibb Co.(BMY) | Common | 110122108 | $32.8K | 445,339 | 0.1% |
| Sarepta Theraputics Inc(SRPT) | Common | 803607100 | $26.9K | 1,412,190 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | Common | 64125C109 | $23.1K | 509,330 | 0.0% |
| Dermira Inc(DERMEUR) | Common | 24983L104 | $21.1K | 721,663 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | Common | 03152W109 | $20.2K | 3,698,665 | 0.0% |
| Immunomedics Inc(IMMU) | Common | 452907108 | $19.9K | 8,556,957 | 0.0% |
| Medivation Inc | Common | 58501N101 | $16.9K | 279,700 | 0.0% |
| Global Blood Therapeeutics Inc | Common | 37890U108 | $16.0K | 963,646 | 0.0% |
| Agenus Inc(AGENEUR) | Common | 00847G705 | $12.6K | 3,099,838 | 0.0% |
| Relypsa Inc | Common | 759531106 | $11.3K | 613,300 | 0.0% |
| Sorrento Therapeutics Inc(SRNE) | Common | 83587F202 | $9.3K | 1,655,274 | 0.0% |
| Teligent Inc. | Common | 87960W104 | $9.2K | 1,290,000 | 0.0% |
| Neuroderm LTD | Common | M74231107 | $9.1K | 557,003 | 0.0% |
| Gilead Sciences Inc(GILD) | Common | 375558103 | $9.1K | 108,500 | 0.0% |
| Vanda Pharmaceuticals Inc(VNDA) | Common | 921659108 | $7.9K | 709,579 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | Common | 60468T105 | $6.6K | 1,214,833 | 0.0% |
| Cascadian Therapeutics Inc | Common | 14740B101 | $5.4K | 5,744,723 | 0.0% |
| Veracyte Inc(VCYT) | Common | 92337F107 | $4.6K | 918,556 | 0.0% |
| Fortress Biotech Inc | Common | 34960Q109 | $3.6K | 1,326,636 | 0.0% |
| Sarepta Theraputics Inc(SRPT)Call | Common | 803607100 | $2.6K | 624,600 | 0.0% |
| Innocoll Holdings PLC | Sh | G4783X105 | $2.6K | 468,148 | 0.0% |
| Trillium Therapeutics Inc | Common | 89620X506 | $2.1K | 228,697 | 0.0% |
| Sarepta Theraputics Inc(SRPT)Put | Common | 803607100 | $2.0K | 1,332,000 | 0.0% |
| Oncobiologics Inc | Common | 68235M105 | $1.6K | 466,667 | 0.0% |
| Pernix Therapeutics Holdings Inc | Convertible Debt | 71426VAK4 | $1.5K | $7,000,000 | 0.0% |
| Assembly Biosciences Inc | Common | 045396108 | $1.4K | 260,982 | 0.0% |
| LA Jolla Pharmaceutical Co(LJPC) | Common | 503459604 | $1.1K | 70,000 | 0.0% |
| Vericel Corp(VCEL) | Common | 92346J108 | $574 | 255,000 | 0.0% |
| Nantkwest Inc | Common | 63016Q102 | $450 | 72,412 | 0.0% |
| Oncobiologics Inc - Warrant A | Warrant | 68235M113 | $107 | 233,333 | 0.0% |
| Oncobiologics Inc - Warrant B | Warrant | 68235M121 | $105 | 233,333 | 0.0% |
| Immunomedics Inc(IMMU)Call | Common | 452907108 | $64 | 453,900 | 0.0% |
| ISh Russell 2000 ETFPut | Put | 464287955 | $19 | 50,000 | 0.0% |